A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants
Clinical trial NCT06411860 · COMPLETED
Trial details
- NCT number
- NCT06411860
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-12
- Primary completion
- 2024-11-29
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.